Tag Archives: Another

AstraZeneca rockets toward Tagrisso sales target with another survival win

AstraZeneca already has a Tagrisso approval for patients with previously untreated, EGFR-mutated lung cancer. But it’s shoring up its case with some clutch new data. Friday, the British drugmaker said Tagrisso had beaten out Roche’s rival drug Tarceva and AstraZeneca’s own Iressa at helping patients live longer. The showing came as part of the phase 3 Flaura… Read More »

OpenNotes notches another big milestone, with 40 million patients now seeing their EHRs

OpenNotes has gained major momentum over the past decade in its efforts to convince providers that patients have the right to access the clinical notes in their electronic health records. This week, the initiative announced that more than 40 million patients across some 200 health systems are using secure portals to see their doctors’ notes.… Read More »

A Rose by Another Name

Medical Practice Jun 21, 2019• By SAURABH JHA, MD Can we reduce over diagnosis by re-naming disease to less anxiety-provoking makes? For example, if we call a 4.1 cm ascending aorta “ecstasia” instead of “aneurysm” will there be less over-treatment? In this episode of Radiology Firing Line Podcast, Saurabh Jha (aka @RogueRad) discusses over diagnosis… Read More »